Chinese medicinal composition for treating acute cerebral infarction
A technology of cerebral infarction and composition, which is applied in the field of traditional Chinese medicine composition and its preparation, to achieve the effects of anticoagulation, anti-blood viscosity, improving circulation, and accelerating the recovery process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0011] From July 2015 to September 2018, 102 cases of acute cerebral infarction were treated with traditional Chinese medicine composition plus salvia miltiorrhiza and ligustrazine, and compared with western medicine alone. The summary is as follows:
[0012] 1. Clinical data
[0013] 1.1 General information The 102 patients with acute cerebral infarction were all hospitalized cases. The western medicine diagnosis met the diagnostic criteria of the Fourth National Cerebrovascular Disease Conference, and they were confirmed by CT scan. They were randomly divided into treatment group and control group. The treatment group included 102 cases, including male 58 cases, 44 females, aged 33-69 years, 102 cases in the control group, including 56 males and 46 females, aged 30-68 years, all patients had cerebral infarction for the first time, 64 cases had no disturbance of consciousness, 60 cases had no obvious Increased intracranial pressure, 8 cases of large area cerebral infarction, ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com